Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) Institutional Ownership

Q: What is CUSIP 45781K105?

CUSIP 45781K105 is the security identifier used in SEC filing datasets for 45781K105 - Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares).

Q: Who owns 45781K105 - Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) based on 13F filings?

Open this security page to review the newest available 13F ownership history, top reported holders, and period-by-period changes.

CUSIP: 45781K105

13F Institutional Holders and Ownership History

Type / Class: Equity / Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares)
Shares outstanding: 93,782,327

Investment Quick Answers

What is CUSIP 45781K105?
CUSIP 45781K105 identifies 45781K105 - Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) in SEC 13F datasets.

Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.

Continue Investment Research

Latest 13F filings for new institutional portfolio disclosures.
Latest Schedule 13D/13G reports for activist and beneficial ownership updates.
Latest 10-Q/10-K reports to cross-check issuer fundamentals.
Recent insider transactions for management buying/selling context.
SEC investors directory and top value investors for manager-level discovery.
All institutional ownership pages to compare adjacent CUSIP pages.

Significant Owners of Innate Pharma SA - Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) based on Schedule 13D/G filings

Filer	Ownership	Change %	Nb Shares	Change %	Reporting Name	Report Period
Sanofi	9%		8,345,387		SANOFI	23 Apr 2025
ASTRAZENECA PLC	8.3%		7,825,501		AstraZeneca PLC	22 Dec 2025
NOVO NORDISK A S	7.8%	-18%	7,333,778	-18%	Novo Nordisk A/S	31 Dec 2025
Bpifrance Participations SA	7.9%		7,319,429		Caisse des depots et consignations	25 Apr 2025